Oncolytics Biotech Inc T.ONC

Recent CMO promotion/ announcement

[canadafan]

Today's announcement of chief medical officer, is great news.
It is clear indication of another cog in the wheel, set to align for phase 3 trial.
My opinion , one of a few subtle mangement changes underway , pre partnership announcement.
Grest, indicator!

[unNoteable]

Oh Canadafan... "Today's announcement of chief medical officer, is great news. It is clear indication of another cog in the wheel, set to align for phase 3 trial. My opinion , one of a few subtle mangement changes underway , pre partnership announcement. Grest, indicator!" Why is this great news ? He won't be doing anything different, as they didn't have a CMO since Rita

[canadafan]

You are correct, but missed a very important piece of information. Rita was quoted. As saying " a CMO will not be needed until phase 3 gets underway". Back to my point, the promoted to CMO to fasilitate the phase 3 process. At last cc, it was said..." we are ramping up towards phase 3 registration " The CMO announcement is part of that. you keep mentioning " to the

[unNoteable]

But we also know that a Phase III won't start until H2 2022... so why promote him now..? extra cost, extra options.. and if he is the man for the job, why didn't he get the role when he joined.. Given ONCY's history of promoting family members (albeit under Brad) I don't trust any promotions in the company. This is news for sake of saying something, anything... what a waste of a

[Noteable]

Why? Because ONCY must be anticipating a partnership announcement soon in advance of the start of the Phase 3 breast cancer study.

[Kswdelux]

Why? Here are a few more thoughts/reasons! If you plan to start a Phase III trial in H2 2022, you don't start planning it on July1st, 2022 of H2 2022, it takes months of planning these registration trials. You start planning them months in advance of the Phase III trail start date. AND if you need to bring in a Partnership in order to fund and complete the Phase III trial, that all takes

[Noteable]

kswdelux - well thought out response and solid points

[westcoast1000]

kwsdelux, Thanks for the thoughtful and informative comment! I hope you are right.

[Kswdelux]

I hope so as well!   There are no guarantees.  Just seems time is running out and things are coimg to a head, the information flow dams will break soon and off we go,,, i really don't know what to expect in the next 3 months with respect to NRs. I will explain... Often in these scenarios I would expect the start of a flow of news that would start raising the SP., all moving

[fox7mf]

Once again Ksw, a well thought out post & I'm in complete agreement. Can't wait to wake up to news of a $15b buyout.

[Noteable]

kswdelux wrote : "... IMHO it's very plauseable that potential buyers are stating do not release the data, we want that kept in house" ... and ... "I think there will be little warning and little SP change before a buyout ... we just wake up to an NR one morning and the deal is done" Yes ... all very plausible. Big pharma's due diligence was being conducted

[Kswdelux]

...(i.e. to see if the data was in-line with expectations... Yes, totally! I don't just pull this out of my under wear... lol I among others have been reading and listening to ONC for years. 1998... yikes ! I also recall comments about Big Pharma due-diligence around end of 2020.   We need to remember that ONC has a completed a sucessful Phase II trial, and ONC could have

[Noteable]

kswdelux -  further to your comments Matt once commented at the start of Bracelet-1 that its partner Pfizer asked that the Bracelet-1 data not be revealed until some undisclosed time which can now be interpreted as in either Q1 or Q2 2022 or at an acquirer's discretion, whichever comes first.  

[Noteable]

I also recall that Matt stated that it was Pfizer who directed ONCY to PrECOG for the implementation and management of the Phase 2 Bracelet-1 study.  https://www.precogllc.org/about

[Kswdelux]

Yes, and it was the same for AWARE-1 with Roche, and it still sounds like we have not seen the final final AWARE-1 yet. Roche's agreement said ONC could not relrease final results until approved by Roche. So not sure what is up there still.

[Capitalista]

I have great hopes for a Roche buyout (it seems most logical), but I'm a bit concerned about the Novartis payout - this will certainly constrain Roche's ability to pay for bolt-on acquisitions such as ONC.  However, it's still a possibility and there are other suitors. 

[inthno]

Just asking and sorry I missed it but could you please direct me to the agreement that states onc cannot release final results until approved by Roche....there has been so many misdirections on the board stating many different times that we have had the final results and thus now the contradiction.

[unNoteable]

@ithno.. Do you rallyu expect a response to that... Noteable and his hapless followers are being led to believe that a buyout is just around the corner. LOOK at the pps performance over the past 20 years... does this look like a company on the cusp of fantastic success... Brad was a charlatan, and Matt seems incapable of speaking the truth... BS company, and plenty of folk wishing it to be a

[Kswdelux]

  Unfortuately, this is my exact issue with these conference calls, fire side chats and BNN interviews. There are all kinds of significant comments made that are not permenantly captured. Just like this last CC, they stated, "results exceeded expectations by statistical significance", but a few months later the audio CC is deleted from the website and no record of those

[inthno]

thanks kswdelux, the explanation seems plausible for sure, my other issue is that I too heard from more than one source that another arm was added in the aware1 trial which one would be led to believe that this information should have been made with a pr to the shareholders. I too have had issues with cc's being deleted when I have tried to go back and confirm information and do know that